A series of fifteen novel dihydropyrimidinone hybrid compounds were synthesized in good yields a multicomponent reaction combined with the Huisgen reaction. The antiproliferative activity was investigated against nine tumor cell lines, and four hybrid compounds (TGI < 10 μM) showed promising antiproliferative activity against the tumor cell lines OVCAR-3 (ovarian), UACC-62 (melanoma) and U251 (glioma). Several hybrid compounds assayed have high TGI values (TGI 147.92-507.82) for the human keratinocyte cell line (HaCat), which reveals selectivity to cancer cells.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151448 | PMC |
| http://dx.doi.org/10.1039/c8md00270c | DOI Listing |
Publication Analysis
Top Keywords
antiproliferative activity
12
hybrid compounds
12
tumor cell
8
cell lines
8
synthesis novel
4
novel perillyl-dihydropyrimidinone
4
perillyl-dihydropyrimidinone hybrids
4
hybrids designed
4
designed antiproliferative
4
activity series
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!